Abstract

Rift Valley fever (RVF) virus is caused by a zoonotic arbovirus that is endemic to eastern and southern Africa. It has also been reported in West and North Africa, Madagascar and the Arabian Peninsula. The virus is transmitted by mosquitoes, but people can also become infected while handling blood or other body fluids of animals and humans with RVF. In 2007, there was a large outbreak of RVF in Kenya, Tanzania, Sudan and Somalia. Outbreaks were also reported in South Africa in 2008–2011. The epidemiology of RVF and factors for disease occurrence in Rwanda are neither clear nor documented. Therefore, we conducted a cross-sectional study from December 2012 to March 2013 to generate baseline information on RVF in cattle. Purposive sampling of cattle (n = 595) was done in six districts, and serum samples were screened with competitive enzyme-linked immunosorbent assay (ELISA). We performed a statistical analysis on the generated data, and risk factors associated with RVF seroprevalence were determined by a simple logistic regression. Overall, RVF seroprevalence was 16.8% (95% confidence interval [CI] [13.8% – 20.0%]). The highest seroprevalence was recorded in Kirehe district (36.9%) followed by Ngoma (22.3%), and the least was recorded in Nyagatare (7.9%). RVF was more likely to occur in adult cattle (19.9% [odds ratio {OR} = 1.88, 95% CI {0.98–3.61}]) compared to young cattle (10.5% [OR = 0.47, 95% CI {0.26–0.83}]). Pure exotic or cross-breeds were significantly exposed to RVF virus (seroprevalence 22.9% [OR = 4.26, 95% CI {1.82–9.99}]) in comparison to 14.1% (OR = 0.55, 95% CI [0.35–0.86]) in local breeds. Sex differences were not statistically significant. These findings indicated that cattle have been exposed to RVF virus in six districts in Rwanda with a significant risk in adult, exotic or cross-breeds in Kirehe district.

Highlights

  • Rift Valley fever virus (RVFV) was initially isolated at Kabete, Kenya, in 1930 (Daubney, Hudson & Garnham 1931)

  • A seroprevalence of 36.9% was recorded in Kirehe district with 95% confidence interval (CI) (25.9– 49.0) followed by Ngoma (22.3%, 95% CI [14.3% – 32.0%]), Bugesera (17.8%, 95% CI [10.9–26.6]) and Kamonyi (14.4, 95% CI [8.1% – 23.0%])

  • The distribution of RVF seroprevalence varied among districts (Figure 1), with high seroprevalence noted in Kirehe (36.9%) and Ngoma (22.3%) districts, which are located in the eastern plateau bordering northern Tanzania

Read more

Summary

Introduction

Rift Valley fever virus (RVFV) was initially isolated at Kabete, Kenya, in 1930 (Daubney, Hudson & Garnham 1931). Rift Valley fever (RVF) is caused by an arbovirus of the family Bunyaviridae. The virus is transmitted by infected mosquitos (Anyamba et al 2009). It is widely spread in Africa from Egypt to South Africa, and the disease has been reported in Madagascar, Saudi Arabia and Yemen (Balenghien et al 2013; Boshra et al 2015; Swanepoel & Coetzer 2004). The infection is described as a febrile disease. Complications such as retinitis, blindness and encephalitis have been reported in 1% – 2% of affected individuals (Madani et al 2003)

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call